Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-07-10

FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Amantadine Hydrochloride (Advagen Pharma Limited), likely implementing labeling changes for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amantadine hydrochloride (amantadine hydrochloride)

Snippet

SUPPL AP for AMANTADINE HYDROCHLORIDE (AMANTADINE HYDROCHLORIDE)